Sponsored content

Eva Ehlich and Anja Fux of Maiwald discuss a board of appeal decision on G 2/21’s interpretation, including a critical review of the interpretation in T 116/18 while denying a request for further review

Jicheng Yang and Jianhui Li of Wanhuida Intellectual Property draw on insights from CNIPA practice in discussing how different drafting approaches to crystal form patent claims impact protection scope and patent validity

Ranjan Narula, Swati Dalal, and Vanshika Oberoi of RNA, Technology and IP Attorneys explore the legal framework, challenges, and enforcement strategies for protecting well-known trademarks in India

Adirek Siriwattasit of Tilleke & Gibbins says Thailand’s new fast-track patent programme for green technologies offers accelerated examinations at no extra cost to applicants, promotes sustainable innovation, and modernises the country’s intellectual property landscape

Min Son of Hanol IP & Law says pharmaceutical R&D in South Korea should be enhanced on the introduction of a clearer legal framework that offers improved market protection for new and modified drugs

Chiu-ling Lin of Saint Island International Patent & Law Offices discusses a ruling by the Supreme Administrative Court in Taiwan that highlights the importance of claim definiteness and enabling requirements in crystalline form patent cases

After decades of debate, Vietnam has recognised the need to create a court dedicated to intellectual property matters, says Loc Xuan Le of T&G Law Firm LLC (TGVN), the local associate firm of Tilleke & Gibbins

Selin Sinem Erciyas and Zeynep Çağla Üstün explore whether Turkey, as a non-EU state party to the European Patent Convention, might still face the Unified Patent Court’s jurisdiction under EU regulations

Charles Feng, Lian Xue, and Yifan Lu of Tahota Law Firm explore Beijing's pioneering role among eight Chinese provinces and municipalities designated to work on the development of the country’s data intellectual property rights framework

New patent and utility model procedures and updated fees form part of a legislative update to the Bangui Agreement that became effective in the new year, explains Craig Kahn of Spoor & Fisher Jersey

Christian Meyer and Gisela Grabow of Maiwald explore proposed changes to new EU provisions aimed at facilitating faster market entry for generics and biosimilars, so as to allegedly bolster competition and enhance patient access

In the second of two interviews with key figures at IPHatch competition winners, Managing IP explores how a start-up is monetising its patents in innovative ways, demonstrating their value beyond just protection